Back |

MATTAWAN, MI October 1, 2009:

Ali S. Faqi, DVM, PhD, DABT, Director of Developmental and Reproductive Toxicology (DART) and Senior Principal Study Director at MPI Research, has accepted an appointment to serve on the Board of Scientific Counselors Computational Toxicology Subcommittee (BOSC), a Federal Advisory Committee under the jurisdiction of the US Environmental Protection Agency. Dr. Faqi, who has published extensively and held many leadership roles in professional organizations, will serve as a BOSC member for one year. He will provide expert judgment on such topics as the quality and type of proposed research programs, excellence in research management practices, and the use of peer review in promoting sound science.

Earlier this year, Dr. Faqi accepted an invitation to serve on the Editorial Board of Reproductive Toxicology, a widely respected journal that focuses on the application of in vitro, in vivo, and clinical research relative to the influence of chemical and physical agents on reproduction. He has presented numerous seminars worldwide dealing with the detection of potential reproductive hazards in preclinical research, including a recent global webinar entitled Juvenile Toxicity Testing: Why, When, and How. This presentation can be accessed throughout 2009 here.

"Dr. Faqi is continually sought out as an expert in his field by colleagues from industry as well as academia," says Dr. Tina Rogers, PhD, MBA, DABT, Director of Research and Executive Vice President at MPI Research. "We are excited about his recent appointment and honored to have him lead the MPI Research DART team." Dr. Faqi received his PhD from the University of Leipzig and his DVM from Somali National University. He earned a diploma of specialization in experimental pharmacology from the University of Milan, Italy and completed a postdoctoral fellowship at the Institute of Toxicology and Embryo Pharmacology at the Free University of Berlin, Germany. In addition to his prior industry experience at Allergan and IIT Research Institute, Dr. Faqi is also a visiting professor for the Faculty of Science, University of Palermo, Italy.

MPI Research, with global headquarters in Mattawan, Michigan, is one of the world's leading providers of comprehensive preclinical and early clinical research and development services, including medical device evaluation and bioanalytical and analytical testing. In addition to a comprehensive array of drug safety evaluation services including a world-class DART group, MPI Research also has a Discovery Center that offers experimental therapeutics (in vivo, molecular and cell-based assays), experimental surgery, molecular imaging, drug metabolism, pharmacokinetics, and immunology. Learn more about the company's commitment to be the best at www.mpiresearch.com.


Home | News